Cite
HARVARD Citation
Chilson, E. et al. (2020). Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in patients with immunocompromising conditions: a review of available evidence. Human vaccines & immunotherapeutics. 16 (11), pp. 2758-2772. [Online].